The morbidity and mortality following a diagnosis of peripheral arterial disease: Long term follow-up of a large database

BMC Cardiovascular Disorders

Volumn 5, Issue , 2005, Pages

  Caro, Jaime ^a,b   Migliaccio Walle, Kristen ^a   Ishak, Khajak J ^c   Proskorovsky, Irina ^c  

^a CARO RESEARCH INSTITUTE   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c Caro Research Institute   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTERY DISEASE; ARTICLE; CANADA; CARDIOVASCULAR RISK; COMORBIDITY; CONTROLLED STUDY; DATA BASE; DEATH; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; STROKE; AGE; ANGINA PECTORIS; CEREBROVASCULAR ACCIDENT; COMPARATIVE STUDY; FACTUAL DATABASE; HYPERTENSION; PERIPHERAL VASCULAR DISEASE; SEX DIFFERENCE;

AGE FACTORS; AGED; ANGINA PECTORIS; COMORBIDITY; DATABASES, FACTUAL; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; MYOCARDIAL INFARCTION; PERIPHERAL VASCULAR DISEASES; RISK FACTORS; SASKATCHEWAN; SEX FACTORS; STROKE;

EID: 26844542906     PISSN: 14712261     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-5-14     Document Type: Article

References (20)

1. Stoffers HE, Rinkens RP, Kester AD, Kaiser V, Knottnerus JA: The prevalence of asymptomatic and unrecognized peripheral arterial occlusive disease. Int J Epidemiol 1996, 25:282-290.
2. Selvin E, Erlinger TP: Prevalence and risk factors for peripheral arterial disease in the United States. Results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 2004,110:738-743.
3. Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, Krook SH, Hunninghake DB, Comerota AJ, Walsh ME, McDermott MM, Hiatt WR: Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001, 286:1317-1324.
4. Criqui MH: Systematic atherosclerosis risk and the mandate for intervention in atherosclerotic peripheral arterial disease. Am J Cardiol 2001, 88 (suppl 2):43-47.
5. Weitz JI, Byrne J, Clagett P, Farkouh ME, Porter JM, Sackett DL, Strandness DE, Taylor LM: Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: A critical review. Circulation 1996, 94:3026-3049.
6. Criqui MH: Peripheral arterial disease - epidemiological aspects. Vasc Med 2001, 6(suppl 1):3-7.
7. Price PF, Mowbray PI, Lee AJ, Rumley A, Lowe GD, Fowkes FG: Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease. Eur Heart J 1999, 20:344-353.
8. McDermott MM, Greenland P, Liu K, Guralnik JM, Crique MH, Dolan NC, Chan C, Celic L, Pearce WH, Schneider JR, Sharma L, Clark E, Gibson D, Martin GJ: Leg symptoms in peripheral arterial disease: Associated clinical characteristics and functional impairment. JAMA 2001, 286:1599-1606.
9. Hooi JD, Stoffers HE, Kester AD, Rinkens PE, Kaiser V, van Ree JW, Knottnerus JA: Risk factors and cardiovascular diseases associated with asymptomatic peripheral arterial occlusive disease. The Limburg PAOD Study. Peripheral Arterial Occlusive Disease. Scand J Prim Health Care 1998, 16:177-182.
10. Fowkes F, Housley E, Cawood EH, MacIntyre CC, Ruckley CV, Prescott RJ: Edinburgh Artery Study: Prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 1991, 20:384-392.
11. Newman AB: Peripheral arterial disease: Insights from population studies of older adults. J Am Geriatr Soc 2000, 48:1157-1162.
12. Downey W, Beck P, McNutt M, Stang MR, Osei W, Nichol J: Health Databases in Saskatchewan. In Strom BL, ed, Pharmacoepidemiology, Third Edition Chichester: Wiley 2000:325-345.
13. Stergachis A, Sheingold S, Luce BR, Psaty BM, Revicki DA: Medical care and cost outcomes after pentoxifylline treatment for peripheral arterial disease. Arch Intern Med 1992, 152:1220-1224.
14. Meijer WT, Grobbee DE, Hunink MGM, Hofman A, Hoes AW: Determinants of peripheral arterial disease in the elderly: The Rotterdam Study. Arch Intern Med 2000, 160:2934-2938.
15. Bowlin SJ, Medalie JH, Flocke SA, Zyzanski SJ, Yaari S, Goldbourt U: Intermittent claudication in 8343 men and 21-year specific mortality follow-up. Ann Epidemiol 1997, 7:180-187.
16. Hiatt WR: Medical treatment of peripheral arterial disease and claudication. N Engl J Med 2001, 344:1608-1621.
17. Howell MA, Colgan MP, Seeger RW, Ramsey DE, Sumner DS: Relationship of severity of lower limb peripheral vascular disease to mortality and morbidity: A six-year follow-up study. J Vasc Surg 1989, 9:691-697.
18. Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, McCann TJ, Browner D: Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992, 326:381-386.
19. Conway DSG, Lip GYH. Comparison of outcomes of patients with symptomatic peripheral artery disease with and without atrial fibrillation (the West Birmingham Atrial Fibrillation Project). Am J Cardiol 2004, 93:1422-1425.
20. McDermott MM, Mehta S, Ahn H, Greenland P: Atherosclerotic risk factors are less intensively treated in patients with peripheral arterial disease than in patients with coronary artery disease. J Gen Intern Med 1997, 12:209-215.